SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-399950
Filing Date
2012-09-21
Accepted
2012-09-21 16:31:03
Documents
2
Period of Report
2012-09-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d414771d8k.htm 8-K 14098
2 INDEPENDENT CONSULTING AGREEMENT d414771dex101.htm EX-10.1 46757
  Complete submission text file 0001193125-12-399950.txt   62172
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 121104502
SIC: 2834 Pharmaceutical Preparations